The role of the hypothalamic-pituitary-adrenal (HPA) axis in cocaine use is
reviewed within the context of two approaches to developing pharmacologica
l treatments in humans: (1) reducing the reinforcing effects of cocaine and
(2) reducing cocaine addict's susceptibility to stress-induced relapse. Th
is review suggests that HPA-axis-suppressing medications are unlikely to bl
ock cocaine's reinforcing effects completely but may be useful in decreasin
g the frequency of use by increasing the addicted individual's resistance t
o stress-induced relapse. Implications for designing inpatient studies to t
est the safety and efficacy of candidate pharmacological agents are discuss
ed. (C) 2001 by The Haworth Press, Inc. All rights reserved.